PHI with Type 1 diabetes (Juvenile diabetes)
How does this condition affect your private health insurance?
Type 1 Diabetes, often called Juvenile Diabetes, is an autoimmune condition where the body's immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. This results in little to no insulin production, a hormone essential for glucose regulation. Without insulin, glucose builds up in the bloodstream, leading to high blood sugar levels. It typically manifests in childhood or adolescence but can occur at any age. Management involves lifelong insulin therapy, blood glucose monitoring, dietary management, and regular exercise to prevent acute and chronic complications.
PKV Risk Assessment
Individual, specialized PHI providers may still insure you, but with a significant surcharge.
Impact on Your Insurance Policy
Duration of Illness (Initial)
Symptoms can develop over weeks to months; the initial acute phase requiring diagnosis and stabilization (especially if Diabetic Ketoacidosis is present) can last several days to a couple of weeks.
Duration of Illness (Lifetime)
Chronic, lifelong condition requiring continuous management.
Cost of Treatment (Initial)
High, ranging from several thousands to tens of thousands of USD, especially if hospitalization for Diabetic Ketoacidosis (DKA) is required, including initial diagnosis, education, and insulin initiation.
Cost of Treatment (Lifetime)
Very high, potentially hundreds of thousands to over a million USD over a lifetime, encompassing daily insulin, glucose monitoring supplies, pump technology, doctor visits, and management of complications.
Mortality Rate
Low with proper management, but there is a persistent risk from acute complications like severe hypoglycemia or DKA, and long-term complications such as cardiovascular disease, kidney failure, or stroke.
Risk of Secondary Damages
Very high without strict management; includes microvascular (retinopathy, nephropathy, neuropathy) and macrovascular (cardiovascular disease, stroke) complications, as well as psychological impact and increased infection risk.
Probability of Full Recovery
Extremely low, near 0%; there is currently no cure, and lifelong insulin therapy is required.
Underlying Disease Risk
Moderate to high; increased probability of other autoimmune conditions such as Celiac disease, Hashimoto's thyroiditis, Graves' disease, or Addison's disease (approximately 20-30% of individuals with T1D develop another autoimmune condition).